对传染病的反意义疗法
Lwanda Abonga Buthelezi1,2, Shandre Pillay1,2, Noxolo Nokukhanya Ntuli1,2
1International Centre for Genetic Engineering and Biotechnology, Cape Town Component, Cape Town 7925, South Africa.
Cells
|August 26, 2023
概括
反感性寡核酸 (ASO) 显示出治疗结核病等传染病的前景,通过在mRNA水平上准致病基因. 本综述探讨了它们的潜力和适应性,以改善药物输送和减少副作用.
科学领域:
- 微生物学 微生物学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 传染病,特别是结核病 (TB),是全球主要的健康负担,在2021年导致160万死亡.
- 耐药性病原体的日益增多需要新的治疗策略.
- 使用反感性寡核酸 (ASO) 的反感性疗法,在mRNA水平上提供向基因抑制.
研究的目的:
- 审查FDA批准的和临床前的反感寡核酸 (ASOs) 治疗传染病的潜力.
- 探索ASO的化学修改,以提高效率和降低毒性.
- 突出ASO在抗击传染病中的治疗应用.
主要方法:
- 在传染病治疗中对反感性寡核酸 (ASOs) 的现有研究的文献综述.
- 对临床前和FDA批准的ASO数据的分析.
- 评估ASO化学修饰及其对药物输送及其副作用的影响.
主要成果:
- 反意义疗法在向致病基因方面表现出特异性.
- ASO能够适应化学修饰,改善药物输送并最大限度地减少不良影响.
- 越来越多的证据支持ASOs作为各种传染病的可行治疗方法的潜力.
结论:
- 反感性寡核酸 (ASO) 是一种有希望的治疗途径,用于感染性疾病,包括结核病.
- ASO对化学修改的适应性提高了它们的安全性和有效性.
- 进一步研究和开发ASO可能会导致针对耐药性感染的新干预措施.
更多相关视频
08:01Detection of Human Immunodeficiency Virus Type 1 HIV-1 Antisense Protein ASP RNA Transcripts in Patients by Strand-Specific RT-PCR
Published on: November 27, 2019
7.6K
12:03Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
7.9K
相关概念视频
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
Viruses with RNA Genomes
56
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
56
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Types of RNA
64.0K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
64.0K
Combined Effects of Drugs: Synergism
4.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.0K
